Abstract
Administration of human normal immunoglobulin (HNIG) post-exposure has been routinely used in Slovakia for outbreak control of hepatitis A, but requires deep intramuscular injection, provides only short-lived protection and is a human blood product. The protective effect of post-exposure administration of an inactivated hepatitis A vaccine was evaluated during 10 outbreaks in Slovakia. Direct contacts of confirmed hepatitis A cases received either: a single dose of hepatitis A vaccine (n = 2171) or immunoglobulin (HNIG, n = 3837). In the HNIG group the number of hepatitis A confirmed cases dropped within the first 7 weeks, however the decrease was not as rapid or as marked as that observed in the vaccinated group where the number of hepatitis A cases dropped within the first 4 weeks after vaccination. Among contacts, 67 cases of hepatitis A were detected during the maximum incubation period of 45 days: 16 cases (0.7%) in the vaccine group and 51 cases (1.3%) in the HNIG group (p < 0.05). After two and three years respectively, 50 and 39 volunteers who had previously received one dose of hepatitis A vaccine received a booster dose and anti-HAV antibodies were measured. Differences in anti-HAV antibody GMCs before and after the booster were statistically significant. The longer time interval (3 years instead of 2) between primary vaccination and booster administration did not seem to impact the magnitude of the booster response. The results of this study show that active post-exposure immunisation with only one dose of inactivated vaccine confers high and long-term protection and effectively controls viral hepatitis A outbreaks.
Similar content being viewed by others
Abbreviations
- ALT:
-
alanine aminotransferase
- AST:
-
aspartate aminotransferase
- ELISA:
-
enzyme-linked immunosorbent assay
- GMC:
-
geometric mean concentrations
- HAV:
-
hepatitis A virus
- HNIG:
-
human normal immunoglobulin
- Ig:
-
immunoglobulin
- IgG:
-
immunoglobulin G
- IgM:
-
immunoglobulin M
- mIU/ml:
-
milli-international units per milliliter
- ml/kg:
-
milliliter per kilogram
- p :
-
p-value
- t :
-
Student’s statistic
References
Advisory Committee on Immunization Practices (ACIP); Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 May 19; 55(RR-7): 1–23
Wheeler C, Vogt TM, Armstrong GL, et al. (2005) An outbreak of hepatitis A associated with green onions. N Engl J Med 353(9): 890–897
Tregnaghi M, Ussher J, Ruttimann R, Jalil M, Tanaka J, Safary A. Effect of the use of vaccine during an epidemic of Hepatitis A in a town in Argentina. Bol Venez Infectol 1997; 7 (Suppl.1)
Trmal J, Jílková E, Zenková E, Ondřej J (1996) Vaccination of children against viral hepatitis A (HAV). Čs Pediat 51(11): 669–673
Werzberger A, Mensch B, Kuter B, et al. (1992) A controlled trial of formalin-inactivated hepatitis A vacccine in healthy children. N Engl J Med 327: 453–457
Kohl I, Príkazský V, Oleár V, van Hoecke C, André FE, Safary A. (1996) Protective effect of post-exposure HavrixTM administration under conditions of viral hepatitis A occurrence FIMSA. Adelaide, Australia, p. 100
Specialized State Health Institute. Analysis of the epidemiological situation in Slovakia in 1993. Banská Bystrica, Slovak Republic 1994: 6–8
Specialized State Health Institute. Analysis of the epidemiological situation in Slovakia in 1995. Banská Bystrica, Slovak Republic, 1996: 16–17
State Health Institute. Analysis of the epidemiological situation in Slovakia in 2001. Banská Bystrica, Slovak Republic, 2002: 24
State Health Institute. Analysis of the epidemiological situation in Slovakia in 2000. Banská Bystrica, Slovak Republic, 2001: 23–26
Behrens RH, Doherty JF (1993) Severe hepatitis A despite passive immunization. Lancet 341: 972
Príkazský V, Oleár V, Černoch A, Safary A, André FE (1994) Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol 44: 457–459
McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. (1996) A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 150: 733–739
Irwin DJ, Millership S (1999) Control of a community hepatitis outbreak using hepatitis A vaccine. Commun Dis Public Health 2(3): 184–187
Poovorawan Y, Tieamboonlers A, Chumdermpadetsuk S, Gluck R, Cryz SJ Jr (1994) Control of a hepatitis A outbreak by active immunization of high-risk susceptible subjects. J Infect Dis 169: 229–230
Taliani G, Gaeta GB (2003) Hepatitis A: Post-exposure prophylaxis. Vaccine 21(19–20): 2234–2237
Sagliocca L, Amoroso P, Stroffolini T, Adamo B, Tosti ME, Lettieri G, Esposito C, Buonocore S, Pierri P, Mele A (1999) Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: A randomised trial. Lancet 353(9159): 1136–9
Hauri AM, Fischer E, Fitzenberger J, Uphoff H, Koenig C (2006) Active immunisation during an outbreak of hepatitis A in a German day-care centre. Vaccine 24(29–30): 5684–5689
Winokur PL, Stapleton JT (1992) Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis 14(2): 580–586
Irwin DJ, Millership S (2001) Antibody responses to Hepatitis A vaccine in healthy adults. Commun Dis Public Health 4(2): 139–40
Khuroo MS (2003) Viral hepatitis in international travellers: Risks and prevention. Int J Antimicrob Agents 21(2): 143–52
van Herck K, van Damme P (2005) Prevention of hepatitis A by Havrix: A review. Expert Rev Vaccines 4(4): 459–71
Acknowledgements
Funding: This study was co-funded by GlaxoSmithKline Biologicals and the Slovak Ministry of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kohl, I., Němeček, V., Summerová, M. et al. Long-term protective effect of post-exposure Havrix TM administration during viral hepatitis Type A outbreaks. Eur J Epidemiol 21, 893–899 (2006). https://doi.org/10.1007/s10654-006-9081-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-006-9081-2